Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Nuo Therapeutics, Inc. | StockGist | StockGist

Companies
AURX
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings AURXSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Nuo Therapeutics, Inc.

Filed Feb 12, 2026

Accepted Feb 11, 2026, 7:00 PM ET

CIK 0001091596

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

3,183,500

Reporting Person

Nuo Therapeutics, Inc.

Person Type

IN

CUSIP: 67059V209

Key Facts

Shares Owned

3,183,500

Recent Filings

Nuo Therapeutics, Inc.1 weeks ago

Nuo Therapeutics, Inc.2 months ago

Nuo Therapeutics, Inc.2 months ago

Nuo Therapeutics, Inc.3 months ago

Nuo Therapeutics, Inc.5 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice